Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS

M Barradas, E Anderton, JC Acosta, SD Li… - Genes & …, 2009 - genesdev.cshlp.org
M Barradas, E Anderton, JC Acosta, SD Li, A Banito, M Rodriguez-Niedenführ, G Maertens…
Genes & development, 2009genesdev.cshlp.org
The INK4a/ARF tumor suppressor locus, a key executor of cellular senescence, is regulated
by members of the Polycomb group (PcG) of transcriptional repressors. Here we show that
signaling from oncogenic RAS overrides PcG-mediated repression of INK4a by activating
the H3K27 demethylase JMJD3 and down-regulating the methyltransferase EZH2. In human
fibroblasts, JMJD3 activates INK4a, but not ARF, and causes p16INK4a-dependent arrest. In
mouse embryo fibroblasts, Jmjd3 activates both Ink4a and Arf and elicits a p53-dependent …
The INK4a/ARF tumor suppressor locus, a key executor of cellular senescence, is regulated by members of the Polycomb group (PcG) of transcriptional repressors. Here we show that signaling from oncogenic RAS overrides PcG-mediated repression of INK4a by activating the H3K27 demethylase JMJD3 and down-regulating the methyltransferase EZH2. In human fibroblasts, JMJD3 activates INK4a, but not ARF, and causes p16INK4a-dependent arrest. In mouse embryo fibroblasts, Jmjd3 activates both Ink4a and Arf and elicits a p53-dependent arrest, echoing the effects of RAS in this system. Our findings directly implicate JMJD3 in the regulation of INK4a/ARF during oncogene-induced senescence and suggest that JMJD3 has the capacity to act as a tumor suppressor.
genesdev.cshlp.org